Calpain system protein expression in basal-like and triple-negative invasive breast cancer

Calpastatin is associated with lymphovascular invasion in breast cancer

(2011) Sarah J. Storr et al.   BREAST

p53 Status Identifies Two Subgroups of Triple-negative Breast Cancers with Distinct Biological Features

(2011) E. Biganzoli et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Subtype and pathway specific responses to anticancer compounds in breast cancer

(2011) L. M. Heiser et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

FOXC1 Is a Potential Prognostic Biomarker with Functional Significance in Basal-like Breast Cancer

(2010) P. S. Ray et al.   CANCER RESEARCH

DNA Repair Protein Biomarkers Associated with Time to Recurrence in Triple-Negative Breast Cancer

(2010) B. M. Alexander et al.   CLINICAL CANCER RESEARCH

Expression of high-molecular-weight cytokeratin (34 E12) is an independent predictor of disease-free survival in patients with triple-negative tumours of the breast

(2010) R. Mehta et al.   JOURNAL OF CLINICAL PATHOLOGY

Triple-negative breast cancer: disease entity or title of convenience?

(2010) Lisa Carey et al.   Nature Reviews Clinical Oncology

Activation of calpain-1 in human carotid artery atherosclerotic lesions

(2009) Isabel Gonçalves et al.   BMC Cardiovascular Disorders

The proteins FABP7 and OATP2 are associated with the basal phenotype and patient outcome in human breast cancer

(2009) H. Zhang et al.   BREAST CANCER RESEARCH AND TREATMENT

Integrative Analysis of Cyclin Protein Levels Identifies Cyclin B1 as a Classifier and Predictor of Outcomes in Breast Cancer

(2009) R. Agarwal et al.   CLINICAL CANCER RESEARCH

Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype

(2008) M. C.U. Cheang et al.   CLINICAL CANCER RESEARCH

Basal-Like Breast Cancer: A Critical Review

(2008) Emad A. Rakha et al.   JOURNAL OF CLINICAL ONCOLOGY